Beyond being a surrogate marker for T cell functionality, this is of critical importance as IFN-γ and TNF-α have been described to play a critical role for treatment success of ACT against solid tumours by inducing anti-tumour immunity from bystander immune cells and by evoking antigen-independent destruction of tumour and stroma cells [56–59]. Here, IFNG is linked to neoplasm.